Business Description
Canton Strategic Holdings Inc. is a New Jersey-based company, founded in 2017, that works to bring blockchain technology into mainstream financial institutions through its focus on Canton Coin and the broader Canton network. Alongside this, the company is developing two medical treatments: a thin-film drug designed to counteract breathing and nervous system emergencies in military and emergency response personnel, and a pill-form version of a medication typically given by IV drip for chronic inflammatory conditions, which would make treatment far more convenient for patients. The company was previously called Tharimmune Inc. before rebranding in February 2026.
